KYNTRA BIO, INC. Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments
KYNTRA BIO, INC. (KYNB) reported Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments of -$8.00 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-09.
Discontinued › Income Statement › Other Income
us-gaap:AvailableforsaleSecuritiesGrossRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2021-11-09
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2021-09-30 was $0.00.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2021-06-30 was -$8.00K.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2021-03-31 was $0.00.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for the quarter ending 2020-12-31 was $0.00.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2020 was -$258.00K.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2018 was $87.00K, a 39.16% decline from fiscal 2017.
- KYNTRA BIO, INC. available-for-sale securities, gross realized gain (loss), excluding other than temporary impairments for fiscal 2017 was $143.00K, a 286.49% increase from fiscal 2016.
| Period end | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 3 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 6 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 9 month | Available-for-sale Securities, Gross Realized Gain (Loss), Excluding Other than Temporary Impairments 12 month |
|---|---|---|---|---|
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | -$8.00K derived: sum of 2 quarters · filed 2021-11-09 | -$8.00K 10-Q · filed 2021-11-09 | -$8.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | -$8.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$8.00K 10-Q · filed 2021-08-09 | -$8.00K derived: sum of 3 quarters · filed 2021-08-09 | -$8.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-10 | $0.00 derived: sum of 2 quarters · filed 2021-05-10 | $0.00 derived: sum of 3 quarters · filed 2021-11-09 | $0.00 derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 derived: sum of 3 quarters · filed 2021-11-09 | -$258.00K 10-K · filed 2021-03-01 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | -$258.00K 10-Q · filed 2021-11-09 | -$258.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | -$258.00K 10-Q · filed 2021-08-09 | -$258.00K derived: sum of 3 quarters · filed 2021-08-09 | -$258.00K derived: sum of 4 quarters · filed 2021-08-09 |
| 2020-03-31 | -$258.00K 10-Q · filed 2021-05-10 | -$258.00K derived: sum of 2 quarters · filed 2021-05-10 | -$258.00K derived: sum of 3 quarters · filed 2021-05-10 | -$258.00K derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $87.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $87.00K derived: sum of 3 quarters · filed 2021-03-01 | $87.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $87.00K derived: sum of 2 quarters · filed 2019-11-12 | $87.00K 10-Q · filed 2019-11-12 | $87.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $87.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $87.00K 10-Q · filed 2019-08-08 | $87.00K derived: sum of 3 quarters · filed 2020-03-02 | $135.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $0.00 10-Q · filed 2018-05-09 | $0.00 derived: sum of 2 quarters · filed 2020-03-02 | $48.00K derived: sum of 3 quarters · filed 2020-03-02 | $113.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $48.00K derived: sum of 2 quarters · filed 2020-03-02 | $113.00K derived: sum of 3 quarters · filed 2020-03-02 | $143.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $113.00K derived: sum of 2 quarters · filed 2018-11-08 | $143.00K 10-Q · filed 2018-11-08 | $143.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-06-30 | $65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $95.00K 10-Q · filed 2018-08-07 | $95.00K derived: sum of 3 quarters · filed 2019-02-27 | $132.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2017-03-31 | $30.00K 10-Q · filed 2018-05-09 | $30.00K derived: sum of 2 quarters · filed 2019-02-27 | $67.00K derived: sum of 3 quarters · filed 2019-02-27 | $67.00K derived: sum of 4 quarters · filed 2019-02-27 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $37.00K derived: sum of 2 quarters · filed 2019-02-27 | $37.00K derived: sum of 3 quarters · filed 2019-02-27 | $37.00K 10-K · filed 2019-02-27 |
| 2016-09-30 | $37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $37.00K derived: sum of 2 quarters · filed 2017-11-08 | $37.00K 10-Q · filed 2017-11-08 | $151.00K derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $0.00 10-Q · filed 2017-08-07 | $114.00K derived: sum of 3 quarters · filed 2018-02-27 | |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $114.00K derived: sum of 2 quarters · filed 2018-02-27 | ||
| 2015-12-31 | $114.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $203.00K 10-K · filed 2018-02-27 | ||
| 2015-09-30 | $89.00K 10-Q · filed 2016-11-08 | |||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | $0.00 10-K · filed 2017-03-01 | ||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | |||
| 2013-12-31 | $301.00K 10-K · filed 2016-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 |